UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Accuracy of predictive ability measures for survival models: P. FLANDRE, R. DEUTSCH AND J. O'QUIGLEY

Statistics in medicine, 2017-09, Vol.36 (20), p.3171-3180

2017

Link zum Volltext

Verfügbarkeit prüfen

Discussion on "Meta-analysis for surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling"

Biometrics, 2012-03, Vol.68 (1), p.242-245

2012

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple-integrase inhibitors-based regimen in a French national survey

Journal of antimicrobial chemotherapy, 2021-09, Vol.76 (9), p.2400-2406

2021

Link zum Volltext

Verfügbarkeit prüfen

Ultrasensitive HIV-1 Viral Load as a Marker of Treatment Choice for Simplification Strategies

Clinical infectious diseases, 2018, Vol.67 (12), p.1883-1889

2018

Link zum Volltext

Verfügbarkeit prüfen

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1

Annals of internal medicine, 2011-09, Vol.155 (6), p.402; author reply 403

2011

Link zum Volltext

Verfügbarkeit prüfen

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1

Annals of internal medicine, 2011-09, Vol.155 (6), p.402

Flandre, Philippe

2011

Link zum Volltext

Verfügbarkeit prüfen

Improved Darunavir Genotypic Mutation Score Predicting Treatment Response for HIV-1 subtype B and non-B Infected Patients Receiving a Salvage Regimen

Journal of antimicrobial chemotherapy, 2016-01, Vol.71 (5), p.1352-1360

2016

Link zum Volltext

Verfügbarkeit prüfen

A Polymorphism at Position 400 in the Connection Subdomain of HIV-1 Reverse Transcriptase Affects Sensitivity to NNRTIs and RNaseH Activity.(Research Article)(Mucleos(t)ide RT inhibitors )

PloS one, 2013-10, Vol.8 (10), p.e74078

2013

Link zum Volltext

Verfügbarkeit prüfen

A Polymorphism at Position 400 in the Connection Subdomain of HIV-1 Reverse Transcriptase Affects Sensitivity to NNRTIs and RNaseH Activity.ide RT inhibitors

PloS one, 2013-10, Vol.8 (10), p.e74078

2013

Link zum Volltext

Verfügbarkeit prüfen

E138K and M1841 mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

AIDS (London), 2012, Vol.26 (13), p.1619-1624

2012

Link zum Volltext

Verfügbarkeit prüfen

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500cells/mm super(3) at the time of diagnosis according to HIV-1 coreceptor tropism

Journal of medical virology, 2012-12, Vol.84 (12), p.1853-1856

2012

Link zum Volltext

Verfügbarkeit prüfen

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500 cells/mm 3 at the time of diagnosis according to HIV‐1 coreceptor tropism

Journal of medical virology, 2012-12, Vol.84 (12), p.1853-1856

2012

Link zum Volltext

Verfügbarkeit prüfen

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism

Journal of medical virology, 2012-12, Vol.84 (12), p.1853

2012

Link zum Volltext

Verfügbarkeit prüfen

Switching to darunavir/ritonavir 800/100mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1

Journal of medical virology, 2013-01, Vol.85 (1), p.8-15

2013

Link zum Volltext

Verfügbarkeit prüfen

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500 cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism

Journal of medical virology, 2012-12, Vol.84 (12), p.1853-1856

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of antiretrovirals on semen quality

Journal of medical virology, 2011-06, Vol.83 (8)

2011

Link zum Volltext

Verfügbarkeit prüfen

Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets

AIDS (London), 2010-01, Vol.24 (3), p.365-371

2010

Link zum Volltext

Verfügbarkeit prüfen

Analysing survival in the presence of an auxiliary variable by D. M. Finkelstein and D. A. Schoenfeld, Statistics in Medicine, 13, 1747-1754 (1994)

Statistics in medicine, 1998-01, Vol.17 (2), p.239-241

Flandre, Philippe

1998

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc: e0127816

PloS one, 2015-06, Vol.10 (6)

2015

Link zum Volltext

Verfügbarkeit prüfen

A Polymorphism at Position 400 in the Connection Subdomain of HIV-1 Reverse Transcriptase Affects Sensitivity to NNRTIs and RNaseH Activity: e74078

PloS one, 2013-10, Vol.8 (10)

2013

Link zum Volltext

Verfügbarkeit prüfen

Does first line anti-retroviral regimen impact risk for chronic kidney disease whatever the risk-group?

AIDS (London), 2016-02

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r‐experienced HIV‐1 infected patients with suppressed HIV‐1 replication: the RADAR study

Journal of the International AIDS Society, 2010-11, Vol.13 (S4), p.P41-P41

2010

Link zum Volltext

Verfügbarkeit prüfen

On the use of magnitude of reduction in HIV-1 RNA in clinical trials: statistical analysis and potential biases

Journal of acquired immune deficiency syndromes (1999), 2002-05, Vol.30 (1), p.59

2002

Link zum Volltext

Verfügbarkeit prüfen

Authors' response

International journal of epidemiology, 1992-10, Vol.21 (5), p.1033-1033

1992

Link zum Volltext

Verfügbarkeit prüfen

A Two-Stage Procedure for Survival Studies with Surrogate Endpoints

Biometrics, 1995-09, Vol.51 (3), p.969-976

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(31)

Sprache

Englisch
(28)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Hiv
(6)
Human Immunodeficiency Virus
(6)
Humans
(6)
Infectious Diseases
(5)
Medical Sciences
(5)
Biological And Medical Sciences
(4)
Hiv Infections - Drug Therapy
(4)
Human Immunodeficiency Virus 1
(4)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(3)
Antiviral Agents
(3)
Female
(3)
Hiv Infections - Virology
(3)
Hiv-1
(3)
Hiv-1 - Genetics
(3)
Human Viral Diseases
(3)
Life Sciences
(3)
Male
(3)
Pharmacology. Drug Treatments
(3)
Viral Diseases
(3)
Virology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

8 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Accuracy of predictive ability measures for survival models: P. FLANDRE, R. DEUTSCH AND J. O'QUIGLEY

Discussion on "Meta-analysis for surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling"

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple-integrase inhibitors-based regimen in a French national survey

Ultrasensitive HIV-1 Viral Load as a Marker of Treatment Choice for Simplification Strategies

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1

Improved Darunavir Genotypic Mutation Score Predicting Treatment Response for HIV-1 subtype B and non-B Infected Patients Receiving a Salvage Regimen

A Polymorphism at Position 400 in the Connection Subdomain of HIV-1 Reverse Transcriptase Affects Sensitivity to NNRTIs and RNaseH Activity.(Research Article)(Mucleos(t)ide RT inhibitors )

A Polymorphism at Position 400 in the Connection Subdomain of HIV-1 Reverse Transcriptase Affects Sensitivity to NNRTIs and RNaseH Activity.ide RT inhibitors

E138K and M1841 mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500cells/mm super(3) at the time of diagnosis according to HIV-1 coreceptor tropism

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500 cells/mm 3 at the time of diagnosis according to HIV‐1 coreceptor tropism

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism

Switching to darunavir/ritonavir 800/100mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500 cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism

Effect of antiretrovirals on semen quality

Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasets

Analysing survival in the presence of an auxiliary variable by D. M. Finkelstein and D. A. Schoenfeld, Statistics in Medicine, 13, 1747-1754 (1994)

HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc: e0127816

A Polymorphism at Position 400 in the Connection Subdomain of HIV-1 Reverse Transcriptase Affects Sensitivity to NNRTIs and RNaseH Activity: e74078

Does first line anti-retroviral regimen impact risk for chronic kidney disease whatever the risk-group?

Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r‐experienced HIV‐1 infected patients with suppressed HIV‐1 replication: the RADAR study

On the use of magnitude of reduction in HIV-1 RNA in clinical trials: statistical analysis and potential biases

Authors' response

A Two-Stage Procedure for Survival Studies with Surrogate Endpoints

Aktive Filter

Suchergebnisse filtern